Revenue (TTM) Chart

View Revenue (TTM) for RVP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (TTM) Chart
Start Trial

Historical Revenue (TTM) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 33.90M
March 31, 2026 37.15M
December 31, 2025 38.27M
September 30, 2025 37.90M
June 30, 2025 38.16M
March 31, 2025 33.75M
December 31, 2024 33.05M
September 30, 2024 38.27M
June 30, 2024 38.25M
March 31, 2024 40.20M
December 31, 2023 43.60M
September 30, 2023 41.99M
June 30, 2023 54.71M
March 31, 2023 61.08M
December 31, 2022 94.82M
September 30, 2022 141.60M
June 30, 2022 154.89M
March 31, 2022 183.05M
December 31, 2021 188.38M
September 30, 2021 160.92M
June 30, 2021 151.66M
March 31, 2021 120.73M
December 31, 2020 81.86M
September 30, 2020 62.50M
June 30, 2020 47.04M
Date Value
March 31, 2020 45.07M
December 31, 2019 41.80M
September 30, 2019 37.43M
June 30, 2019 35.66M
March 31, 2019 33.53M
December 31, 2018 33.27M
September 30, 2018 34.52M
June 30, 2018 35.07M
March 31, 2018 35.24M
December 31, 2017 34.49M
September 30, 2017 32.47M
June 30, 2017 30.90M
March 31, 2017 30.83M
December 31, 2016 29.83M
September 30, 2016 29.51M
June 30, 2016 30.16M
March 31, 2016 29.30M
December 31, 2015 29.55M
September 30, 2015 33.09M
June 30, 2015 34.50M
March 31, 2015 34.66M
December 31, 2014 34.52M
September 30, 2014 31.35M
June 30, 2014 29.62M
March 31, 2014 29.65M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

View Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (TTM) Benchmarks

View Revenue (TTM) Benchmarks
Start Trial
Abbott Laboratories 46.58B
AngioDynamics, Inc. 320.17M
Alphatec Holdings, Inc. 815.05M
AtriCure, Inc. 569.62M
Baxter International, Inc. 11.47B